← Back to Clinical Trials
Recruiting NCT06574139

NCT06574139 Evaluation of Unstained

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06574139
Status Recruiting
Phase
Sponsor The Policy & Research Group
Condition Teen Pregnancy Prevention
Study Type INTERVENTIONAL
Enrollment 1,500 participants
Start Date 2024-09-16
Primary Completion 2028-03

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age 22 Years
Study Type INTERVENTIONAL
Interventions
UnstainedLike

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,500 participants in total. It began in 2024-09-16 with a primary completion date of 2028-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this randomized trial is to learn if the Unstained intervention has a positive impact on the sexual health behaviors of sexually active youth between the ages of 14 and 22 years old who are at risk for or involved in the legal system. The primary research questions it aims to answer are: * Three months after being offered the intervention, does Unstained impact youth's receipt of sexually transmitted infection testing in the past four months? * Nine months after being offered the intervention, does Unstained impact youth's frequency of having vaginal and anal sex without condoms in the past four months? Researchers will compare participants randomized to receive Unstained (treatment group) to participants randomized to receive a control condition that contains no sexual or reproductive health information (control group). Participants randomized to the treatment group will be offered Unstained as a virtual, individual-based intervention delivered during three \~60 minute sessions over a 3-6 week period. Participants randomized to the control group will be offered a virtually delivered control condition.

Eligibility Criteria

Inclusion Criteria: * United States resident * Owns or has regular access to a personal device with internet access * Comfortable reading, speaking, and writing in English * Has had vaginal or anal sex in the past 3 months * At risk for or involved in the legal system Exclusion Criteria: * Currently trying to start a pregnancy * Currently in jail or being detained in a facility * Enrolled in an ongoing PRG-run TPP study * Identified as fraudulent * Participating in another known OPA-funded research study

Contact & Investigator

Central Contact

Hilary Demby, MPH

✉ hilary@policyandresearch.com

📞 504.865.1545

Principal Investigator

Sarah Walsh, PhD

PRINCIPAL INVESTIGATOR

The Policy & Research Group

Frequently Asked Questions

Who can join the NCT06574139 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, up to 22 Years, studying Teen Pregnancy Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06574139 currently recruiting?

Yes, NCT06574139 is actively recruiting participants. Contact the research team at hilary@policyandresearch.com for enrollment information.

Where is the NCT06574139 trial being conducted?

This trial is being conducted at New Orleans, United States.

Who is sponsoring the NCT06574139 clinical trial?

NCT06574139 is sponsored by The Policy & Research Group. The principal investigator is Sarah Walsh, PhD at The Policy & Research Group. The trial plans to enroll 1,500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology